Impact of adverse events, treatment modifications, and dose intensity on survival among patients with advanced renal cell carcinoma treated with first-line sunitinib: A medical chart review across ten centers in five European countries

  1. Porta, C.
  2. Levy, A.
  3. Hawkins, R.
  4. Castellano, D.
  5. Bellmunt, J.
  6. Nathan, P.
  7. Mcdermott, R.
  8. Wagstaff, J.
  9. Donnellan, P.
  10. Mccaffrey, J.
  11. Vekeman, F.
  12. Neary, M.P.
  13. Diaz, J.
  14. Mehmud, F.
  15. Duh, M.S.
Revista:
Cancer Medicine

ISSN: 2045-7634

Any de publicació: 2014

Volum: 3

Número: 6

Pàgines: 1517-1526

Tipus: Article

DOI: 10.1002/CAM4.302 GOOGLE SCHOLAR lock_openAccés obert editor
Font de les dades: Scopus